Taiho Expands Cancer Pipeline With ADCs In $400m Araris Buy

Add-On To Japanese Pharma’s Small Molecule Efforts

 
• By Mandy Jackson
  
Araris and Taiho first partnered on ADC development in November 2023 (Shutterstock)

More from Deals

More from Scrip